Antimicrobial treatment of bacterial prostatitis

European Urology, Supplement

Volumn 2, Issue 2, 2003, Pages 23-26

  Naber, K G ^a  

^a Urologische Klinik   (Germany)

Author keywords

Antimicrobial therapy; Bacterial prostatitis; Uropathogens

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; LOMEFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; BACTERIUM CULTURE; BLASTOMYCES DERMATITIDIS; CHLAMYDIA TRACHOMATIS; CHRONIC PROSTATITIS; CLINICAL TRIAL; COCCIDIOIDES IMMITIS; CONFERENCE PAPER; DRUG INDICATION; ENTEROCOCCUS; HISTOPLASMA CAPSULATUM; HUMAN; MYCOBACTERIUM TUBERCULOSIS; MYCOPLASMA; PRIORITY JOURNAL; PROSTATITIS; PSEUDOMONAS AERUGINOSA; TREATMENT INDICATION; UREAPLASMA; URINE CULTURE;

EID: 0037336345     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1569-9056(02)00196-3     Document Type: Conference Paper

References (26)

1. Schaeffer AJ. Prostatitis: US perspective. Int J Antimicrob Agents 1999;11:205-11.
2. Workshop Committee of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Chronic Prostatitis Workshop, Bethesda, MD, 7-8 December 1995.
3. Naber KG, Bergman B, Bishop MC, Bjerklund Johansen TE, Botto H, Lobel B, et al. and European Association of Urology (EAU). EAU guidelines on urinary and male genital tract infections. Nijmegen (The Netherlands): European Association of Urology; 2001. p. 1-75.
4. Meares EM, Stamey TA. Bacteriologic localization patterns in bacterial prostatitis and urethris. Invest Urol 1968;5:492-518.
5. Krieger JN, Berger RE, Ross SO, Rothman I, Muller CH. Seminal fluid findings in men with nonbacterial prostatitis and prostatodynia. J Androl 1996;17:310-8.
6. Weidner W, Jantos C, Schiefer HG, Haidl G, Friedrich HJ. Semen parameters in men with and without proven chronic prostatitis. Arch Androl 1991;26:173-83.
7. Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection 1991;19(Suppl 3):119-25.
8. Naber KG, Weidner W. Prostatitis, epididymitis and orchitis. In: Armstrong D, Cohen J, editors. Infectious diseases. London: Mosby; 1999. p. 1-58.
9. Naber KG. Antibiotic treatment of chronic bacterial prostatitis. In: Nickel JC, editor. Textbook of prostatitis. Oxford (UK): Isis Medical Media; 1999. p. 285-92.
10. Bjerklund Johansen TE, Grüneberg RN, Guibert J, Hofstetter A, Lobel B, Naber KG, et al. The role of antibiotics in the treatment of chronic prostatitis: a consensus statement. Eur Urol 1998;34:457-66.
11. Mayersak JS. Transurethral ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome. A report of a 5 year clinical study of 75 patients. Int Surg 1998;83:347-9.
12. Jimenez Cruz JF, Boronat F, Gallego J. Treatment of chronic prostatitis: intraprostatic injection under echography control. J Urol 1988;139:967-70.
13. De la Rosette JJMCH, Hubregste MR, Meuleman EJH, Stolk-Engelaar MVM, Debruyne FMJ. Diagnosis and treatment of 409 patients with prostatitis syndromes. Urology 1993;41:301-7.
14. Ohkawa M, Yamaguchi K, Tokunaga S, Nakashima T, Shoda R. Antimicrobial treatment for chronic prostatitis as a means of defining the role of Ureaplasma urealyticum. Urol Int 1993;51:129-32.
15. Schaeffer AJ, Darras FS. The efficacy of norfloxacin in the treatment of chronic bacterial prostatitis refractory to trimethoprim-sulfamethoxazole and/or carbenicillin. J Urol 1990;144:690-3.
16. Petrikkos G, Peppas T, Giamarellou H, Poulios K, Zouboulis P, Sfikakis P. Four year experience with norfloxacin in the treatment of chronic bacterial prostatitis. In: 17th International Congress on Chemotherapy, Berlin, Germany, 1991 [Abstract 1302].
17. Pust RA, Ackenheil-Koppe HR, Gilbert P, Weidner W. Clinical efficacy of ofloxacin (Tarivid) in patients with chronic bacterial prostatitis: preliminary results. J Chemother 1989;1(Suppl 4):469-71.
18. Weidner W, Schiefer HG, Dalhoff A. Treatment of chronic bacterial prostatitis with ciprofloxacin. Results of a one-year follow-up study. Am J Med 1987;82(Suppl 4A):280-3.
19. Weidner W, Schiefer HG, Brähler E. Refractory chronic bacterial prostatitis: a re-evaluation of ciprofloxacin treatment after a median follow-up of 30 months. J Urol 1991;146:350-2.
20. Pfau A. Therapie der unteren Harnwegsinfektionen beim Mann unter besonderer Berücksichtigung der chronischen bakteriellen Prostatitis. Akt Urol 1987;18:31-3.
21. Pfau A. The treatment of chronic bacterial prostatitis. Infection 1991;19(Suppl 3):160-4.
22. Naber KG, Busch W, Focht J, the German Prostatitis Study Group. Ciprofloxacin in the treatment of chronic bacterial prostatitis: a prospective, non-comparative multicentre clinical trial with long-term follow-up. Int J Antimicrob Agents 2000;14:143-9.
23. Naber KG, the European Lomefloxacin Prostatitis Study Group. Lomefloxacin versus ciprofloxacin in the treatment of chronic bacterial prostatitis. Int J Antimicrob Agents 2002;20:18-27.
24. Naber KG, Giamarellou H. Proposed study design in prostatitis. Infection 1994;22(Suppl 1):59-60.
25. Litwin MS, McNaughton-Collins M, Fowler Jr FJ, Nickel FC, Calhoun EA, Pontari MA, et al. National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of new outcome measure. J Urol 1999;162:369-75.
26. Barbalias GA, Nikiforidis G, Liatsikos EN. Alpha-blockers for the treatment of chronic prostatitis in combination with antibiotics. J Urol 1998;159:883-7.